Menu

• Ask a Health Expert about COAGULATION FACTOR V LEVEL DECREASED
• Post Your Side Effect related to COAGULATION FACTOR V LEVEL DECREASED
• COAGULATION FACTOR V LEVEL DECREASED and FDA Warnings
• COAGULATION FACTOR V LEVEL DECREASED in Patients Wiki
• Report COAGULATION FACTOR V LEVEL DECREASED in Drug Side Effect Survey

COAGULATION FACTOR V LEVEL DECREASED side effect

What is COAGULATION FACTOR V LEVEL DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Augmentin Side Effects Report #5646049-2
Consumer or non-health professional from FRANCE reported AUGMENTIN problem on Feb 15, 2008. Female patient, 39 years of age, was diagnosed with lung disorder and was treated with AUGMENTIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, coagulation factor v level decreased, haemodynamic instability, hepatic ischaemia, hepatic lesion, hepatic necrosis, hepatitis alcoholic, hepatitis toxic, hepatocellular injury, . AUGMENTIN dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5466851-X
VELCADE problem was reported by a Physician from FRANCE on Sept 10, 2007. Male patient, 68 years of age, weighting 165.3 lb, was diagnosed with b-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: cholecystitis, coagulation factor v level decreased, coagulopathy, cytomegalovirus infection, escherichia sepsis, hepatic failure, histiocytosis haematophagic, hypercoagulation, . VELCADE dosage: 2.90 MG, INTRAVENOUS; 2.70 MG, INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLONE, FLUCONAZOLE. Patient was hospitalized. Patient died on 08/15/2007.

Rifadin Side Effects Report #5573502-2
Consumer or non-health professional from reported RIFADIN problem on Dec 18, 2007. Male patient, 46 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIFADIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, alanine aminotransferase increased, coagulation factor v level decreased, hepatitis fulminant, hepatocellular damage, jaundice, nausea, prothrombin level decreased, vomiting, . RIFADIN dosage: unknown. During the same period patient was treated with PIRILENE, RIFATER. Patient recovered.

Enbrel Side Effects Report #5749558-0
ENBREL problem was reported by a Physician from FRANCE on May 15, 2008. Male patient, 42 years of age, was diagnosed with psoriatic arthropathy and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased, autoimmune hepatitis, coagulation factor v level decreased, hepatitis acute, hypergammaglobulinaemia, prothrombin time prolonged, . ENBREL dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient was hospitalized. Patient recovered.


Enbrel Side Effects Report #5750217-9
Health Professional from FRANCE reported ENBREL problem on May 20, 2008. Male patient, 42 years of age, was diagnosed with psoriatic arthropathy and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased, autoimmune hepatitis, coagulation factor v level decreased, hepatitis acute, hypergammaglobulinaemia, prothrombin time prolonged, . ENBREL dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5717693-9
ENBREL problem was reported by a Health Professional from FRANCE on Apr 11, 2008. Male patient, 42 years of age, was diagnosed with psoriatic arthropathy and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody increased, autoimmune hepatitis, coagulation factor v level decreased, hepatitis acute, hypergammaglobulinaemia, prothrombin time prolonged, . ENBREL dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient was hospitalized. Patient recovered.